Contemporary issues in rheumatic fever and chronic rheumatic heart disease

Circulation

Volumn 130, Issue 24, 2014, Pages 2181-2188

  Essop, Mohammed R ^a   Peters, Ferande ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

diagnosis; echocardiography; epidemiology; rheumatic heart disease

Indexed keywords

PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; CARDITIS; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE COURSE; ECHOCARDIOGRAPHY; GENETIC PREDISPOSITION; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; MITRAL VALVE REGURGITATION; MORTALITY; PREDICTIVE VALUE; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SCREENING TEST; STREPTOCOCCAL PHARYNGITIS; HEALTH; MASS SCREENING; PREVALENCE; TRENDS;

ECHOCARDIOGRAPHY; GLOBAL HEALTH; HUMANS; MASS SCREENING; PREVALENCE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE;

EID: 84917678612     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009857     Document Type: Review

References (81)

1. Parkinson J. Rheumatic fever and heart disease: the Harveian oration. Lancet. 1945;246:657-663.
2. WHO Global HIV report 2013. www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013gr2013/UNAIDS-Global- Report-2013-en.pdf. Accessed October 2, 2014.
3. WHO. Global tuberculosis report 2013. Geneva, Switzerland. http://www. who.int/tb/publications/global-report/en. Accessed October 2, 2014.
4. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155-168.
5. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. Circulation. 1985;72:1155-1162.
6. Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, Roth SJ, Tait VF, Thompson JA, Daly JA, Kaplan EL. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 1987;316:421-427.
7. Omurzakova NA, Yamano Y, Saatova GM, Shukurova SM, Mirzakhanova MI, Kydyralieva RB, Jumagulova AS, Mirrakhimov EM, Seisenbaev ASh, Nishioka K, Nakajima T. Rheumatologic services in Central Asian countries: current state of development of rheumatology in Central Asia. Int J Rheum Dis. 2009;12:288-292.
8. Pastore S, De Cunto A, Benettoni A, Berton E, Taddio A, Lepore L. The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology (Oxford). 2011;50:396-400.
9. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever rheumatic heart disease. Clin Epidemiol. 2011;3:67-84.
10. Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility antigens with rheumatic fever. J Clin Invest. 1986;77:2019-2026.
11. Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis. 2001;33:806-814.
12. Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM. Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS One. 2011;6:e25326.
13. Lee GM, Wessels MR. Changing epidemiology of acute rheumatic fever in the United States. Clin Infect Dis. 2006;42:448-450.
14. Wessels MR. Streptococcal pharyngitis. N Engl J Med. 2011;364:648-655.
15. Shulman ST, Stollerman G, Beall B, Dale JB, Tanz RR. Temporal changes in streptococcal M protein types and the near disappearance of acute rheumatic fever in the United States. Clin Infect Dis. 2006;42:441-447.
16. Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J, Kaplan EL, Musser JM, Hill HR. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics. 2004;113(3 pt 1):e168-e172.
17. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma, and rheumatic fever. Lancet. 1996;347:1271-1272.
18. Haidan A, Talay SR, Rohde M, Sriprakash KS, Currie BJ, Chhatwal GS. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet. 2000;356: 1167-1169.
19. Engel ME, Muhamed B, Whitelaw AC, Musvosvi M, Mayosi BM, Dale JB. Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage. Pediatr Infect Dis J. 2014;33:208-210.
20. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009;9:611-616.
21. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as the cause of left ventricular dilation in active rheumatic carditis. J Am Coll Cardiol. 1993;22:826-829.
22. Veasy LG, Tani LY. A new look at acute rheumatic mitral regurgitation. Cardiol Young. 2005;15:568-577.
23. Kinsley RH, Girdwood RW, Milner S. Surgical treatment during the acute phase of rheumatic carditis. Surg Annu. 1981;13:299-323.
24. Kinsley RH, Pocock WA. Rheumatic fever and rheumatic heart disease. In: Barlow JB, ed. Perspectives on the Mitral Valve. Philadelphia, PA: FA Davis Company; 1987:227-245.
25. Marcus RH, Sareli P, Pocock WA, Meyer TE, Magalhaes MP, Grieve T, Antunes MJ, Barlow JB. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol. 1989;63:577-584.
26. Barlow JB, Marcus RH, Pocock WA, Barlow CW, Essop R, Sareli P. Mechanisms and management of heart failure in active rheumatic carditis. S Afr Med J. 1990;78:181-186.
27. Lembo NJ, DellItalia LJ, Crawford MH, Miller JF, Richards KL, ORourke RA. Mitral valve prolapse in patients with prior rheumatic fever. Circulation. 1988;77:830-836.
28. Vasan RS, Shrivastava S, Vijayakumar M, Narang R, Lister BC, Narula J. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation. 1996;94:73-82.
29. Essop MR, Omar T. Rheumatic fever. In: Crawford MH, DiMarco JP, Paulus WJ, eds. Cardiology. New York, NY: Mosby/Elsevier; 2009:1215-1223.
30. Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe rheumatic mitral valve disease in a developing country. Ann Intern Med. 1994;120:177-183.
31. Jones TD. Diagnosis of rheumatic fever. JAMA. 1944;126:481-484.
32. Rustein DD, Bauer W, Dorfman A, Gross RE, Lichty JA, Taussig HB, Whittemore R. Report of the Committee on Standards and Criteria for Programs of Care of the Council of Rheumatic Fever and Congenital Heart Disease of the American Heart Association. Jones Criteria (Modified) for guidance in the diagnosis of rheumatic fever. Circulation. 1956;13:617-620.
33. Stollerman GH, Markowitz M, Taranta A, Wannamaker LW, Whittemore R. Report of the Ad hoc Committee on Rheumatic Fever and Congenital Heart Disease of the American Heart Association: Jones Criteria (Revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1965;32:664-668.
34. Shulman ST, Kaplan EL, Bisno AL, Millard HD, Amren DP, Houser H, Sanders WE, Durack DT, Watanakunakorn C. Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the American Heart Association. Jones Criteria (Revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1984;70:204A-208A.
35. Dajani AS, Ayoub E, Bierman FZ, Bisno AL, Denny FW, Durack DT, Ferreri P, Freed M, Gerber M, Kaplan EL, Karchmer AW, Markowitz M, Rahimtoola SH, Shulman ST, Taranta A, Taubert KA, Wilson W. Special writing group of the Committee on Rheumatic Fever, Endocarditis and Kawasaki disease of the Council of Cardiovascular Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever: Jones criteria: update. JAMA. 1992;268:2069-2073.
36. Ferrieri P; Jones Criteria Working Group. Proceedings of the Jones Criteria workshop. Circulation. 2002;106:2521-2523.
37. WHO. Rheumatic Fever and Rheumatic Heart Disease: Report of a WHO Expert Consultation. Geneva 29 Oct-1 Nov 2001. Geneva, Switzerland: WHO; 2004.
38. Carapetis JR, Brown A, Wilson NJ, Edwards KN; Rheumatic Fever Guidelines Writing Group. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust. 2007;186:581-586.
39. Atatoa-Carr P, Lennon D, Wilson N; New Zealand Rheumatic Fever Guidelines Writing Group. Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. N Z Med J. 2008;121:59-69.
40. Narula J, Chandrasekhar Y, Rahimtoola S. Diagnosis of active rheumatic carditis. The echoes of change. Circulation. 1999;100:1576-1581.
41. Veasy LG. Time to take soundings in acute rheumatic fever. Lancet. 2001;357:1994-1995.
42. Vijayalakshmi IB, Vishnuprabhu RO, Chitra N, Rajasri R, Anuradha TV. The efficacy of echocardiographic criterions for the diagnosis of carditis in acute rheumatic fever. Cardiol Young. 2008;18:586-592.
43. Wilson N. Echocardiography and subclinical carditis: guidelines that increase sensitivity for acute rheumatic fever. Cardiol Young. 2008;18:565-568.
44. Ramakrishnan S. Echocardiography in acute rheumatic fever. Ann Pediatr Cardiol. 2009;2:61-64.
45. Tubridy-Clark M, Carapetis JR. Subclinical carditis in rheumatic fever: a systematic review. Int J Cardiol. 2007;119:54-58.
46. Arajo FD, Goulart EM, Meira ZM. Prognostic value of clinical and Doppler echocardiographic findings in children and adolescents with significant rheumatic valvular disease. Ann Pediatr Cardiol. 2012;5:120-126.
47. Anabwani GM, Bonhoeffer P. Prevalence of heart disease in school children in rural Kenya using colour-flow echocardiography. East Afr Med J. 1996;73:215-217.
48. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470-476.
49. Carapetis JR, Hardy M, Fakakovikaetau T, Taib R, Wilkinson L, Penny DJ, Steer AC. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med. 2008;5:411-417.
50. Sadiq M, Islam K, Abid R, Latif F, Rehman AU, Waheed A, Azhar M, Khan JS. Prevalence of rheumatic heart disease in school children of urban Lahore. Heart. 2009;95:353-357.
51. Bhaya M, Panwar S, Beniwal R, Panwar RB. High prevalence of rheumatic heart disease detected by echocardiography in school children. Echocardiography. 2010;27:448-453.
52. Paar JA, Berrios NM, Rose JD, Caceres M, Pena R, Perez W, Chen-Mok M, Jolles E, Dale JB. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol. 2010;105:1809-1814.
53. Reeves BM, Kado J, Brook M. High prevalence of rheumatic heart disease in Fiji detected by echocardiography screening. J Paediatr Child Health. 2011;47:473-478.
54. Saxena A, Ramakrishnan S, Roy A, Seth S, Krishnan A, Misra P, Kalaivani M, Bhargava B, Flather MD, Poole-Wilson PP. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart. 2011;97:2018-2022.
55. Beaton A, Okello E, Lwabi P, Mondo C, McCarter R, Sable C. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation. 2012;125:3127-3132.
56. Marijon E, Tafflet M, Jouven X. Time to use ultrasound and not stethoscopes for rheumatic heart disease screening. Nat Clin Pract Cardiovasc Med. 2008;5:E1-E3.
57. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet. 2012;379:953-964.
58. Roberts K, Colquhoun S, Steer A, Remenyi B, Carapetis J. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol. 2013;10:49-58.
59. Marijon E, Celermajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira B, Mocumbi AO, Paquet C, Sidi D, Jouven X. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 2009;120:663-668.
60. Roberts K, Maguire G, Brown A, Atkinson D, Remenyi B, Wheaton G, Kelly A, Kumar RK, Su JY, Carapetis JR. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation. 2014;129:1953-1961.
61. Colquhoun SM, Carapetis JR, Kado JH, Steer AC. Rheumatic heart disease and its control in the Pacific. Expert Rev Cardiovasc Ther. 2009;7:1517-1524.
62. Colquhoun SM, Carapetis JR, Kado JH, Reeves BM, Remenyi B, May W, Wilson NJ, Steer AC. Pilot study of nurse-led rheumatic heart disease echocardiography screening in Fiji-a novel approach in a resource-poor setting. Cardiol Young. 2013;23:546-552.
63. Araujo FDR, Goulart EMA, Meira ZMA. Use of Doppler echocardiography to support the decision to discontinue secondary prophylaxis for patients with rheumatic fever and normal auscultation. Pediatr Cardiol. 2013;34:1073-1080.
64. Mirabel M, Celermajer DS, Ferreira B, Tafflet M, Perier MC, Karam N, Mocumbi AO, Jani DN, Sidi D, Jouven X, Marijon E. Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. Eur Heart J Cardiovasc Imaging. 2012;13:1024-1029.
65. Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabel M, Mocumbi AO, Mota C, Paar J, Saxena A, Scheel J, Stirling J, Viali S, Balekundri VI, Wheaton G, Zuhlke L, Carapetis J. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat Rev Cardiol. 2012;9:297-309.
66. Carapetis J, Paar J, Cherian T. Standardization of Epidemiologic Protocols for Surveillance of Post-streptococcal Sequelae: Acute Rheumatic Fever, Rheumatic Heart Disease and Acute Post-streptococcal Glomerulonephritis. Bethesda, MD: National Institute of Allergy and Infectious Diseases; 2006. http://www.niaid.nih.gov/topics/strepThroat/Documents/groupasequelae.pdf.
67. Tani LY. Echocardiographic screening for rheumatic heart disease. Circulation. 2014;129:1912-1913.
68. Joint report by the Rheumatic Fever Working Party of the Medical research Council of Great Britain and the Subcommittee of the Principal Investigators of the American Council on Rheumatic Fever and Congenital Heart Disease. The evolution of rheumatic heart disease in children. Circulation. 1960;XXII:503-515.
69. Joseph N, Madi D, Kumar GS, Nelliyanil M, Saralaya V, Rai S. Clinical spectrum of rheumatic Fever and rheumatic heart disease: a 10 year experience in an urban area of South India. N Am J Med Sci. 2013;5:647-652.
70. Gasse B, Baroux N, Rouchon B, Meunier JM, Fremicourt ID, DOrtenzio E. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study. BMC Public Health. 2013;13:131.
71. Zuhlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep. 2013;15:343.
72. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009;374:934-947.
73. WHO Global Health Data Repository. http://apps.who.int/gho/data/node. main.
74. Karthikeyan G, Mayosi BM. Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation. 2009;120:709-713.
75. Irlam J, Mayosi BM, Engel M, Gaziano TA. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013;6:343-351.
76. Mayosi B, Robertson K, Volmink J, Adebo W, Akinyore K, Amoah A, Bannerman C, Biesman-Simons S, Carapetis J, Cilliers A, Commerford P, Croasdale A, Damasceno A, Dean J, Dean M, de Souza R, Filipe A, Hugo-Hamman C, Jurgens-Clur SA, Kombila-Koumba P, Kotzenberg C, Lawrenson J, Manga P, Matenga J, Mathivha T, Mntla P, Mocumbi A, Mokone T, Ogola E, Omokhodion S, Palweni C, Pearce A, Salo A, Thomas B, Walker K, Wiysonge C, Zaher S. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J. 2006;96(3 pt 2):246.
77. Robertson KA, Volmink JA, Mayosi BM on behalf of the writing committee. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa -the awareness surveillance advocacy prevention (A.S.A.P) programme. S Afr Med J. 2006;96:241-245.
78. Karthikeyan G, Zuhlke L, Engel M, Rangarajan S, Yusuf S, Teo K, Mayosi BM. Rationale and design of a global rheumatic heart registry: the REMEDY study. Am Heart J. 2012;163:535-540.
79. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM; World Heart Federation. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013;10:284-292.
80. Herbert N, George A, Baroness Masham of Ilton, Sharma V, Oliver M, Oxley A, Raviglione M, Zumla AI. World TB Day 2014: finding the missing 3 million. Lancet. 2014;383:1016-1018.
81. Carapetis JR, Zuhlke LJ. Global research priorities in rheumatic fever and rheumatic heart disease. Ann Pediatr Cardiol. 2011;4:4-12.